Trials / Sponsors / Applied Therapeutics, Inc.
Applied Therapeutics, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Confirmatory Study of Govorestat in CMT-SORD Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD) | Phase 3 | 2025-10-01 |
| Active Not Recruiting | Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficie Hereditary Neuropathy Caused by SORD Deficiency | Phase 2 / Phase 3 | 2022-01-01 |
| Unknown | AT-007 in Adult Subjects With Classic Galactosemia (CG) Classic Galactosemia | Phase 3 | 2021-10-01 |
| Completed | Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia Classic Galactosemia | Phase 2 / Phase 3 | 2021-03-20 |
| Active Not Recruiting | Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Diabetic Cardiomyopathies | Phase 3 | 2019-09-20 |
| Completed | Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia Classic Galactosemia | Phase 1 / Phase 2 | 2019-06-21 |